This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Mann, D. L. Articles by Willerson, J. T. Search for Related Content PubMed PubMed Citation Articles by Mann, D. L. Articles by Willerson, J. T.

Left Ventricular Assist Devices and the Failing Heart

A Bridge to Recovery, a Permanent Assist Device, or a Bridge Too Far?

Douglas L. Mann, MD; ; James T. Willerson, MD

Key Words: Editorials • heart-assist device • heart failure • ventricles

The field of cardiac mechanical assist devices has achieved a number of striking technical breakthroughs over the past 40 years.¹ Emblematic of the type of important technical accomplishments that have been achieved in this field has been the development of the portable, battery-driven left ventricular assist device (LVAD) for patients with intractable cardiac failure. Although LVADs have been used primarily as a "bridge to transplantation," a number of centers have now begun to implant LVADs as an alternative to transplantation.² Indeed, as the technology in this field improves, it is entirely conceivable that LVADs will evolve into small, unobtrusive devices that will run on small, portable, long-lasting battery supplies that will not require external connection to the outside. This, in turn, will allow LVADs to serve as a very reliable alternative to transplantation for many patients with advanced heart failure who cannot receive transplants or who cannot be weaned from LVAD support.

Thus far, the clinical experience with LVADs as a bridge to transplantation has consistently shown dramatic improvements in cardiac output^{3 4} and New York Heart Association functional class.^{4 5} Importantly, these clinical changes have been attended by concomitant decreases in levels of neurohormones^{6 7} and cytokines,⁸ suggesting that LVAD support may alter the heart failure "milieu." In an effort to explain these salutary changes in clinical status, investigators have turned to more basic studies and begun to examine myocardial ultrastructure before and after LVAD implantation. These latter studies have shown decreased myocyte necrosis^{9 10} and apoptosis,¹¹ decreased myocytolysis,³ and improved myocyte contractility.¹² . . . [Full Text of this Article]

This article has been cited by other articles:

				G. L. Brower, J. D. Gardner, M. F. Forman, D. B. Murray, T. Voloshenyuk, S. P. Levick, and J. S. Janicki The relationship between myocardial extracellular matrix remodeling and ventricular function. Eur. J. Cardiothorac. Surg., October 1, 2006; 30(4): 604 - 610. [Abstract] [Full Text] [PDF]

				D. Mancini and D. Burkhoff Mechanical Device-Based Methods of Managing and Treating Heart Failure Circulation, July 19, 2005; 112(3): 438 - 448. [Abstract] [Full Text] [PDF]

				J. K. F. Hon and M. H. Yacoub Bridge to recovery with the use of left ventricular assist device and clenbuterol Ann. Thorac. Surg., June 1, 2003; 75(90060): S36 - 41. [Abstract] [Full Text] [PDF]

				H. T. Tevaearai, G. B. Walton, A. D. Eckhart, J. R. Keys, and W. J. Koch Heterotopic transplantation as a model to study functional recovery of unloaded failing hearts J. Thorac. Cardiovasc. Surg., December 1, 2002; 124(6): 1149 - 1156. [Abstract] [Full Text]

				N. de Jonge, D. F. van Wichen, M. E. I. Schipper, J. R. Lahpor, F. H. J. Gmelig-Meyling, E. O. Robles de Medina, and R. A. de Weger Left ventricular assist device in end-stage heart failure: persistence of structural myocyte damage after unloading: An immunohistochemical analysis of the contractile myofilaments J. Am. Coll. Cardiol., March 20, 2002; 39(6): 963 - 969. [Abstract] [Full Text] [PDF]

				M. Flesch, K. B. Margulies, H.-C. Mochmann, D. Engel, N. Sivasubramanian, and D. L. Mann Differential Regulation of Mitogen-Activated Protein Kinases in the Failing Human Heart in Response to Mechanical Unloading Circulation, November 6, 2001; 104(19): 2273 - 2276. [Abstract] [Full Text] [PDF]

				Y. Y. Li, Y. Feng, C. F. McTiernan, W. Pei, C. S. Moravec, P. Wang, W. Rosenblum, R. L. Kormos, and A. M. Feldman Downregulation of Matrix Metalloproteinases and Reduction in Collagen Damage in the Failing Human Heart After Support With Left Ventricular Assist Devices Circulation, September 4, 2001; 104(10): 1147 - 1152. [Abstract] [Full Text] [PDF]

				Y. Ochiai, L. A.R. Golding, A. L. Massiello, A. L. Medvedev, R. L. Gerhart, J.-F. Chen, M. Takagaki, and K. Fukamachi In vivo hemodynamic performance of the Cleveland Clinic CorAide blood pump in calves Ann. Thorac. Surg., September 1, 2001; 72(3): 747 - 752. [Abstract] [Full Text] [PDF]

				S. Westaby HEART FAILURE: Non-transplant surgery for heart failure Heart, May 1, 2000; 83(5): 603 - 603. [Full Text]